Analysis of K-ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 10, 2005, Pages 1584-1590

  Mukawa, Kenichiroh ^a   Fujii, Shigehiko ^a,b   Takeda, Jun ^a   Kitajima, Kazuaki ^a   Tominaga, Keiichi ^a   Chibana, Yoko ^a   Fujita, Mikio ^a   Ichikawa, Kazuhito ^a   Tomita, Shigeki ^a   Ono, Yuko ^a   Imura, Johji ^a   Kawamata, Hitoshi ^a   Chiba, Tsutomu ^b   Hiraishi, Hideyuki ^a   Terano, Akira ^a   Fujimori, Takahiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Colorectal tumor; Cyclooxygenase 2; Gastrin; K ras; Laterally spreading tumor

Indexed keywords

CYCLOOXYGENASE 2; GASTRIN;

ADULT; AGED; ARTICLE; COLONOSCOPY; COLORECTAL TUMOR; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LATERALLY SPREADING TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR DIAGNOSIS; GENE FREQUENCY; GENETICS; METABOLISM; METHODOLOGY; ONCOGENE RAS; PATHOLOGY; POINT MUTATION; STAINING;

COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; GASTRINS; GENE FREQUENCY; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STAINING AND LABELING;

EID: 33644664682     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03897.x     Document Type: Article

References (38)

1. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988 319 : 525 32.
2. Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA. Kirsten ras mutations in patients with colorectal cancer: The multicenter 'RASCAL' study. J. Natl Cancer Inst. 1998 90 : 675 84.
3. Andreyev HJ, Norman AR, Cunningham D et al. Kirsten ras mutations in patients with colorectal cancer: The 'RASCAL II' study. Br. J. Cancer 2001 85 : 692 6.
4. Yamagata S, Muto T, Uchida Y et al. Polypoid growth and K-ras codon 12 mutation in colorectal cancer. Cancer 1995 75 : 953 7.
5. Chiang JM, Chou YH, Chou TB. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer. Cancer Res. 1998 58 : 3289 93.
6. Crawford BE, Stromeyer FW. Small nonpolypoid carcinomas of the large intestine. Cancer 1983 51 : 1760 3.
7. Fujimori T, Satonaka K, Yamamura-Idei Y, Nagasako K, Maeda S. Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int. J. Cancer 1994 57 : 51 5.
8. Yukawa M, Fujimori T, Maeda S, Tabuchi M, Nagasako K. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumors. Gut 1994 35 : 1258 61.
9. Mueller J, Mueller E, Hoepner I et al. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: A comparative immunohistochemical study. J. Pathol. 1996 180 : 259 65.
10. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 1993 25 : 455 61.
11. Kudo S, Yamano Y, Tamura T et al. Laterally spreading tumors. Ito Cho (Stomach Intestine) 1996 31 : 167 78 (In Japanese with an English abstract).
12. Ohno Y, Terai T, Ogihara T, Hirai S, Miwa H. Laterally spreading tumor: Clinicopathological study in comparison with the depressed type of colorectal tumor. J. Gastroenterol. Hepatol. 2001 16 : 770 6.
13. Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T, Fujimori T. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors. J. Gastroenterol. Hepatol. 2000 15 : 1151 7.
14. Masferrer JL, Seibert K, Zweifel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl Acad. Sci. USA 1992 89 : 3917 21.
15. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 1991 266 : 12866 72.
16. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl Acad. Sci. USA 1997 94 : 3336 40.
17. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 1995 55 : 2556 9.
18. Fujita M, Fukui H, Kusaka T et al. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas. J. Gastroenterol. Hepatol. 2000 15 : 1277 81.
19. Bissonnette M, Khare S, von Lintig FC et al. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: Effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res. 2000 60 : 4602 9.
20. Taylor MT, Lawson KR, Ignatenko NA et al. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells. Cancer Res. 2000 60 : 6607 10.
21. Bakke I, Qvigstad G, Sandvik AK, Waldum HL. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand. J. Gastroenterol. 2001 36 : 1128 33.
22. Ryberg B, Axelson J, Hakanson R, Sundler F, Mattsson H. Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. Gastroenterology 1990 98 : 33 8.
23. Iwase K, Evers BM, Hellmich MR et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 1997 113 : 782 90.
24. Van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993 104 : 1099 107.
25. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995 109 : 1142 53.
26. Singh P, Owlia A, Varro A, Dai B, Rajaraman S, Wood T. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res. 1996 56 : 4111 15.
27. Singh P, Velasco M, Given R, Varro A, Wang TC. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology 2000 119 : 162 71.
28. Nakata H, Wang SL, Chung DC, Westwick JK, Tillotson LG. Oncogenic ras induces gastrin gene expression in colon cancer. Gastroenterology 1998 115 : 1144 53.
29. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma. Tokyo : Kanehara, 1997.
30. Jiang W, Kahn SM, Guillem JG, Lu S-H, Weinstein IB. Rapid detection of ras oncogenes in human tumors: Applications to colon, esophageal and gastric cancer. Oncogene 1989 4 : 923 8.
31. Yamashita K, Arimura Y, Shimizu H et al. Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors). J. Gastroenterol. 2003 38 : 69 73.
32. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994 107 : 1183 8.
33. Sano H, Kawahito Y, Wilder RL et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995 55 : 3785 9.
34. Chapple KS, Scott N, Guillou PJ, Coletta PL, Hull MA. Interstitial cell cyclooxygenase-2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas. J. Pathol. 2002 198 : 435 41.
35. Elder DJ, Baker JA, Banu NA, Moorghen M, Paraskeva C. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J. Pathol. 2002 198 : 428 34.
36. Sheng H, Shao J, Dubois RN. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res. 2001 61 : 2670 5.
37. Finley GG, Koski RA, Melhem MF, Pipas JM, Meisler AI. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma. Cancer Res. 1993 53 : 2919 26.
38. Guo YS, Cheng JZ, Jin GF, Gutkind JS, Hellmich MR, Townsend Jr CM. Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. J. Biol. Chem. 2002 277 : 48755 63.